GSK

GSK · LSE · GBp

1,779.50 GBpChange from previous close: −0.86%Absolute change: −15.50 GBp

Close · October 2, 2026

At a glance

Revenue growth
+4.11%
2025 vs 2024
Net income growth
+121.98%
2025 vs 2024
Net margin
17.5%
2024: 8.2%

Financial data

Amounts in millions of GBP; per-share values in GBP; shares in millions.

Balance sheet · Quarterly
ItemQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Total assets61,73862,86961,11861,33959,25860,70559,46358,04958,06658,51159,00560,862
Current assets17,55917,76117,51017,84217,67318,08516,99717,29816,76417,20518,64421,240
Cash and equivalents3,1053,4423,3973,2963,5994,4643,8703,1922,9622,7902,9363,177
Short-term investments1.01.09.010.020.021.021.020.021.01,30542.03,506
Receivables8,0747,9377,3748,3047,6977,5016,9357,8677,7787,2917,4038,874
Inventory6,2826,1575,9246,1186,0726,0005,6695,9185,8595,7025,4985,480
Net property, plant and equipment10,03210,03810,04810,1329,9189,97110,0739,7259,8239,8679,9579,454
Goodwill7,3817,2877,0187,1176,7346,9266,9826,6806,9606,9786,8116,973
Other intangible assets16,80218,13816,74816,86515,37616,25815,51515,01015,47315,66714,76815,295
Long-term investments9559581,1261,0839771,0321,1961,1041,1521,2771,1921,142
Current liabilities21,53422,42921,39121,33420,37820,83121,69721,45920,34519,84621,06822,390
Accounts payable14,34214,2103,53514,55113,64813,8403,46213,47313,32713,7073,71814,692
Long-term debt14,00214,06814,08214,89415,30416,47413,70313,24413,57715,15614,15415,993
Total debt18,23819,05617,72017,75017,354———————
Total liabilities44,56145,44745,16245,58744,90447,05146,37744,59644,29645,28246,21048,243
Total equity (incl. minority)17,17717,42215,95615,75214,35413,65413,08613,45313,77013,22912,79512,619
Retained earnings11,46411,59010,95710,0168,7978,3078,7678,1878,5837,9357,7437,017
Minority interest-468-430-421-396-437-503-585-555-602-611-552-514